FY17
Assets44.65
Net Worth3.87
Total Debt21.17
RevenueAnnualised basis66.05
EBITDAAnnualised basis4.38
PATAnnualised basis0.66
EBITDA Margin (%)6.63
At a glance
Updated 2026-09-06Vaishali Pharma is an IPO with an issue size of ₹14.23 crore, proposed for listing on NSE EMERGE.
Issue details
Listing atNSE EMERGE
Issue size₹14.23 Cr
Price band—–—
Grey market
GMP page ↗Latest GMPNO GMP
GMP / upper priceNO DATA
Est. listingNO DATA
GMP is unofficial sentiment data, not an exchange price.
Subscription demand
Full bidding ↗NO DATAWaiting for a verified live exchange update.
Company
Financial performance
Year-wise operating scale, profitability and balance-sheet context.Assets45.80₹ Cr · -7.3% vs prior year
Net Worth3.24₹ Cr · +1.3% vs prior year
FY16
Assets49.41
Net Worth3.20
Total Debt19.76
RevenueAnnualised basis66.71
EBITDAAnnualised basis3.73
PATAnnualised basis-0.03
EBITDA Margin (%)5.59
FY15
Assets45.80
Net Worth3.24
Total Debt24.04
RevenueAnnualised basis94.56
EBITDAAnnualised basis3.97
PATAnnualised basis0.16
EBITDA Margin (%)4.20
Peer comparison
| Company | EPS | P/E | RoNW | NAV |
|---|---|---|---|---|
| Vaishali Pharma IPO | — | 72.00 x | — | — |
| Bio Medica IPO | — | 13.45 x | — | — |
| Goldline Pharmaceutical IPO | — | 14.56 x | — | — |
| Speciality Medicines IPO | — | 10.49 x | — | — |
Registrar & lead managers
Lead managers
- Location
Offer documents
Data is reconciled from multiple public IPO sources. Official exchange filings and offer documents remain the source of truth. Last verified 2026-09-06.
IPO UPDATE ALERTS
Register for IPO Updates →Track Vaishali Pharma without missing an update
Register for subscription, GMP, allotment and listing notifications.